| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
132.54(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$414.13 - $539.68 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 17 |
| Guru Rank Value : 22.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
45,506 |
52,053 |
52,427 |
77,577 |
| Total Sell Value |
$23,439,266 |
$26,598,808 |
$26,775,666 |
$38,325,083 |
| Total People Sold |
5 |
6 |
7 |
8 |
| Total Sell Transactions |
6 |
8 |
10 |
15 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Haytaian Peter D |
EVP & Pres Carelon & CarelonRx |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,008 |
23,362 |
|
- |
|
| Haytaian Peter D |
EVP & Pres Carelon & CarelonRx |
• – – |
2023-03-01 |
4 |
D |
$469.03 |
$284,701 |
D/D |
(607) |
11,354 |
|
- |
|
| Norwood Felicia F |
EVP & President, GBD |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,008 |
38,197 |
|
- |
|
| Norwood Felicia F |
EVP & President, GBD |
• – – |
2023-03-01 |
4 |
D |
$469.03 |
$232,170 |
D/D |
(495) |
26,189 |
|
- |
|
| Todt Blair Williams |
EVP and Chief Legal Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,717 |
12,628 |
|
- |
|
| Todt Blair Williams |
EVP and Chief Legal Officer |
• – – |
2023-03-01 |
4 |
D |
$469.03 |
$174,479 |
D/D |
(372) |
7,911 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,849 |
71,963 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• – – |
2023-03-01 |
4 |
D |
$469.03 |
$289,392 |
D/D |
(617) |
60,114 |
|
- |
|
| Boudreaux Gail |
President and CEO |
• • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
44,297 |
153,477 |
|
- |
|
| Boudreaux Gail |
President and CEO |
• • – |
2023-03-01 |
4 |
D |
$469.03 |
$1,158,973 |
D/D |
(2,471) |
109,180 |
|
- |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,409 |
3,262 |
|
- |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2023-03-01 |
4 |
D |
$469.03 |
$30,018 |
D/D |
(64) |
1,853 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,781 |
68,375 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2023-03-01 |
4 |
D |
$469.03 |
$275,321 |
D/D |
(587) |
55,594 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,568 |
18,725 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2023-03-01 |
4 |
D |
$469.03 |
$137,426 |
D/D |
(293) |
14,157 |
|
- |
|
| Todt Blair Williams |
EVP and Chief Legal Officer |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,983 |
8,283 |
|
- |
|
| Norwood Felicia F |
EVP & President, GBD |
• – – |
2022-12-30 |
4 |
D |
$512.97 |
$899,749 |
D/D |
(1,754) |
26,684 |
|
- |
|
| Todt Blair Williams |
EVP and Chief Legal Officer |
• – – |
2022-12-01 |
4 |
D |
$525.25 |
$61,454 |
D/D |
(117) |
4,300 |
|
- |
|
| Boudreaux Gail |
President and CEO |
• • – |
2022-11-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
111,415 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2022-11-01 |
4 |
D |
$544.53 |
$43,018 |
D/D |
(79) |
14,450 |
|
- |
|
| Haytaian Peter D |
EVP & Pres Carelon & IngenioRx |
• – – |
2022-11-01 |
4 |
D |
$544.53 |
$108,906 |
D/D |
(200) |
11,961 |
|
- |
|
| Strable-Soethout Deanna D |
Director |
– • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
200 |
200 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2022-06-09 |
4 |
S |
$487.45 |
$3,091,872 |
D/D |
(6,328) |
14,529 |
|
-0% |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2022-06-09 |
4 |
OE |
$232.04 |
$1,806,785 |
D/D |
6,328 |
20,857 |
|
- |
|
634 Records found
|
|
Page 3 of 26 |
|
|
1.35 (0.26%) 
